Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0000950170-25-012420·Bindley Capital Partners I, LLC
Schedule 13D ownership disclosure
Guardian Pharmacy Services Inc
Class A Common Stock, par value $0.001 per share · CUSIP: 40145W101
Event date: 2025-01-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Bindley Capital Partners I, LLCReported CIK 0002038820
Shares: 6,100,176 · Class: 26.8%
- William E. BindleyReported CIK 0000903539
Shares: 6,100,176 · Class: 26.8%
- Thomas J. Salentine, Jr.Reported CIK 0002037899
Shares: 6,135,890 · Class: 27%
- Pharmacy Investors, LLCReported CIK 0002038519
Shares: 1,413,940 · Class: 6.2%
- John AckermanReported CIK 0002037898
Shares: 1,413,940 · Class: 6.2%
- Cardinal Equity Fund, L.PReported CIK 0001432819
Shares: 471,057 · Class: 2.1%
- Fred P. BurkeReported CIK 0002037972
Shares: 1,298,826 · Class: 5.7%
- David K. MorrisReported CIK 0002037977
Shares: 641,869 · Class: 2.8%
- G. Kendall ForbesReported CIK 0002038507
Shares: 608,570 · Class: 2.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-012420
- Form type
- SCHEDULE 13D
- Filer
- Bindley Capital Partners I, LLC
- CIK
- CIK 2038820
- Filed
- Feb 03, 2025
- Reporting period
- Jan 28, 2025
- Description
- Schedule 13D beneficial ownership